APA

Glas M., Coch C., Trageser D., Dassler J., Simon M., Koch P., Mertens J., Quandel T., Gorris R., Reinartz R., Wieland A., Von Lehe M., Pusch A., Roy K., Schlee M., Neumann H., Fimmers R., Herrlinger U., Brüstle O., Hartmann G., Besch R. & Scheffler B. (20140417). Targeting the cytosolic innate immune receptors RIG-I and MDA5 effectively counteracts cancer cell heterogeneity in glioblastoma. : Stem cells (Dayton, Ohio).

Chicago

Glas Martin, Coch Christoph, Trageser Daniel, Dassler Juliane, Simon Matthias, Koch Philipp, Mertens Jerome, Quandel Tamara, Gorris Raphaela, Reinartz Roman, Wieland Anja, Von Lehe Marec, Pusch Annette, Roy Kristin, Schlee Martin, Neumann Harald, Fimmers Rolf, Herrlinger Ulrich, Brüstle Oliver, Hartmann Gunther, Besch Robert and Scheffler Björn. 20140417. Targeting the cytosolic innate immune receptors RIG-I and MDA5 effectively counteracts cancer cell heterogeneity in glioblastoma. : Stem cells (Dayton, Ohio).

Harvard

Glas M., Coch C., Trageser D., Dassler J., Simon M., Koch P., Mertens J., Quandel T., Gorris R., Reinartz R., Wieland A., Von Lehe M., Pusch A., Roy K., Schlee M., Neumann H., Fimmers R., Herrlinger U., Brüstle O., Hartmann G., Besch R. and Scheffler B. (20140417). Targeting the cytosolic innate immune receptors RIG-I and MDA5 effectively counteracts cancer cell heterogeneity in glioblastoma. : Stem cells (Dayton, Ohio).

MLA

Glas Martin, Coch Christoph, Trageser Daniel, Dassler Juliane, Simon Matthias, Koch Philipp, Mertens Jerome, Quandel Tamara, Gorris Raphaela, Reinartz Roman, Wieland Anja, Von Lehe Marec, Pusch Annette, Roy Kristin, Schlee Martin, Neumann Harald, Fimmers Rolf, Herrlinger Ulrich, Brüstle Oliver, Hartmann Gunther, Besch Robert and Scheffler Björn. Targeting the cytosolic innate immune receptors RIG-I and MDA5 effectively counteracts cancer cell heterogeneity in glioblastoma. : Stem cells (Dayton, Ohio). 20140417.